Recipharm | Investor relations

Investor relations

Find out more about our financial situation and outlook.

03 Dec 2020, 14:51 The share

Recipharm Annual report 2019

Read Recipharm's Annual Report 2019

Finansiell kalender

2020.12.15

DNB’s Virtual Nordic Healthcare Conference

Recipharm's CEO Thomas Eldered and CFO Tobias Hägglöv will be presenting and meeting investors.

2021.02.18

Interim report January – December 2020

Will be published at 07:45 am CET.

2021.04.20

Annual Report 2020

Recipharm publishes Annual Report 2020

2021.05.06

Interim report January – March 2021

Will be published at 07:45 am CET.

Financial reports

Recipharm AB publishes its interim report for the third quarter 2020

2020-11-05

Recipharm AB publishes its interim report for the second quarter 2020

2020-07-27

Recipharm AB publishes its interim report January-March 2020

2020-05-07

See all financial reports

Financial press releases

Recipharm announces signature of letter of intent for aseptic fill-finish manufacturing of Moderna’s COVID-19 vaccine candidate (mRNA-1273)

2020-11-24

Recipharm and Medspray establish joint venture to exploit novel softmist technology for pharmaceutical applications

2020-11-17

Invitation to the presentation of Recipharm’s interim report for the third quarter 2020

2020-11-02

See all financial press releases

2020.11.05

Q3 report summary

Interim report - Q3 2020

Read the whole report here

Listen to the webcast presentation here

Q3 report 2020 presentation

2020.07.27

Q2 report summary

Interim report - Q2 2020

Read the whole report here

Listen to the webcast presentation here

Q2 report 2020 presentation

2020.05.07

Q1 report summary

Interim report January - March 2020

Read the whole report here

Listen to the webcast presentation here

Q1 report 2020 presentation

2020.02.20

Q4 report summary

Full year report 2019

Read the whole report here

Listen to the webcast presentation here

Q4 report 2019 presentation